X-ray structure of the hRORα LBD at 1.63 Å:: Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα

被引:233
作者
Kallen, JA [1 ]
Schlaeppi, JM
Bitsch, F
Geisse, S
Geiser, M
Delhon, I
Fournier, B
机构
[1] Novartis Pharma AG, Cent Technol Prot Struct Unit, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Cent Technol Biomol Prod Unit, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Bone Metab Unit, Arthrit & Bone Metab, CH-4002 Basel, Switzerland
关键词
ROR; atherosclerosis; cholesterol; nuclear receptor; coactivator; transcription factor;
D O I
10.1016/S0969-2126(02)00912-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoic acid-related orphan receptor alpha (RORalpha) is an orphan member of the subfamily 1 of nuclear hormone receptors. No X-ray structure of RORalpha has been described so far, and no ligand has been identified-We describe the first crystal structure of the ligand binding domain (LBD) of RORalpha, at 1.63 Angstrom resolution. This structure revealed a ligand present in the ligand binding pocket (LBP), which was identified by X-ray crystallography as cholest-5-en-3beta-of (cholesterol). Moreover, RORalpha transcriptional activity could be modulated by changes in intracellular cholesterol level or mutation of residues involved in cholesterol binding. These findings suggest that RORalpha could play a key role in the regulation of cholesterol homeostasis and thus represents an important drug target in cholesterol-related diseases.
引用
收藏
页码:1697 / 1707
页数:11
相关论文
共 50 条
[1]   Disruption of retinoid-related orphan receptor β changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice [J].
André, E ;
Conquet, F ;
Steinmayr, M ;
Stratton, SC ;
Porciatti, V ;
Becker-André, M .
EMBO JOURNAL, 1998, 17 (14) :3867-3877
[2]   Coactivators for the orphan nuclear receptor RORα [J].
Atkins, GB ;
Hu, X ;
Guenther, MG ;
Rachez, C ;
Freedman, LP ;
Lazar, MA .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1550-1557
[3]  
Auwerx J, 1999, CELL, V97, P161
[4]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[5]   Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects [J].
Billas, IML ;
Moulinier, L ;
Rochel, N ;
Moras, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7465-7474
[6]   Difference structure-factor normalization for heavy-atom or anomalous-scattering substructure determinations [J].
Blessing, RH ;
Smith, GD .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 :664-670
[7]   Natural ligands of nuclear receptors have conserved volumes [J].
Bogan, AA ;
Cohen, FE ;
Scanlan, TS .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (08) :679-681
[8]   Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains [J].
Bourguet, W ;
Vivat, V ;
Wurtz, JM ;
Chambon, P ;
Gronemeyer, H ;
Moras, D .
MOLECULAR CELL, 2000, 5 (02) :289-298
[9]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[10]   A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood [J].
Brown, MS ;
Goldstein, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11041-11048